Buy canadian cipro

SALT LAKE buy canadian cipro CITY, Sept https://www.msamentoring.com/buying-cipro-in-usa/. 22, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq buy canadian cipro. HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Bryan Hunt, CFO, and Adam Brown, SVP of Investor Relations and FP&A, will participate in Cantor Global Healthcare Conference including a fireside chat presentation on Thursday, September 30, 2021 at 1:20 p.m. ET.

A webcast link will be available at https://ir.healthcatalyst.com/investor-relations. About Health Catalyst Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed. Health Catalyst Investor Relations Contact.

Adam BrownSenior Vice President, Investor Relations and FP&A+1 (855)-309-6800ir@healthcatalyst.com Health Catalyst Media Contact. Amanda Hundtamanda.hundt@healthcatalyst.com+1 (575) 491-0974SALT LAKE CITY, Aug. 31, 2021 /PRNewswire/ -- August 31, 2021 – Health Catalyst, Inc. ("Health Catalyst," Nasdaq. HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced Matt Revis will join the Health Catalyst leadership team.

Revis will report directly to Health Catalyst Chief Operating Officer Paul Horstmeier. Revis will continue to lead the Twistle business, a role he is familiar with, having served as Twistle's President and Chief Operating Officer prior to the acquisition of the patient engagement technology company by Health Catalyst in July 2021."Given the opportunity for patient engagement technology to transform healthcare, it is an incredible time to lead Twistle by Health Catalyst. As we enter the next stage of our journey, it's my aim to drive even greater care outcomes for our healthcare clients and their patients," said Revis. "I look forward to working with my fellow team members across the Health Catalyst organization to ensure Twistle reaches its full potential and delivers on our mission of massive, measurable healthcare improvement."Prior to joining Twistle in 2019, Revis served as a Head of Product at Jibo, where he was responsible for the full product development lifecycle of the world's first social robot for the home. Jibo was named the 2017 Product of the Year by Time Magazine.

Revis also served in leadership roles at Nuance Communications where he helped build the company's healthcare strategy through a mix of product innovation, M&A, and strategic partnership development."Matt's experience driving healthcare strategy and growth through product innovation and strategic partnerships will no doubt help further our global mission of healthcare improvement," said Dan Burton, CEO of Health Catalyst. "We are grateful for his leadership and dedication to Twistle by Health Catalyst and are excited to have him as member of our world class leadership team."About Health CatalystHealth Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.Media Contact:Amanda Hundtamanda.hundt@healthcatalyst.com 575-491-0974 View original content to download multimedia:https://www.prnewswire.com/news-releases/matt-revis-joins-health-catalyst-leadership-team-301364818.htmlSOURCE Health Catalyst.

Cipro gram positive

They will also help cultivate future growth http://really-delicious.com/online-pharmacy-kamagra/ in cipro gram positive this rapidly progressing field. The 10 guiding principles identify areas where the International Medical Device Regulators Forum (IMDRF), international standards organizations and other collaborative bodies could work to advance GMLP. Areas of collaboration include research, creating educational tools and resources, international harmonization, and consensus standards, which may help inform regulatory policies and regulatory guidelines. We envision cipro gram positive these guiding principles may be used to.

Adopt good practices that have been proven in other sectors Tailor practices from other sectors so they are applicable to medical technology and the health care sector Create new practices specific for medical technology and the health care sector As the AI/ML medical device field evolves, so too must GMLP best practice and consensus standards. Strong partnerships with our international public health partners will be crucial if we are to empower stakeholders to advance responsible innovations in this area. Thus, we expect this initial collaborative work can inform our broader cipro gram positive international engagements, including with the IMDRF. We welcome your continued feedback through the public docket (FDA-2019-N-1185) at Regulations.gov, and we look forward to engaging with you on these efforts.

The Digital Health Center of Excellence is spearheading this work for the FDA. Contact us directly cipro gram positive at Digitalhealth@fda.hhs.gov, software@mhra.gov.uk, and mddpolicy-politiquesdim@hc-sc.gc.ca. Guiding principles Multi-Disciplinary Expertise Is Leveraged Throughout the Total Product Life Cycle. In-depth understanding of a model's intended integration into clinical workflow, and the desired benefits and associated patient risks, can help ensure that ML-enabled medical devices are safe and effective and address clinically meaningful needs over the lifecycle of the device.

Good Software Engineering and Security Practices Are cipro gram positive Implemented. Model design is implemented with attention to the "fundamentals". Good software engineering practices, data quality assurance, data management, and robust cybersecurity practices. These practices include methodical risk management and design process that can appropriately capture and communicate design, implementation, and cipro gram positive risk management decisions and rationale, as well as ensure data authenticity and integrity.

Clinical Study Participants and Data Sets Are Representative of the Intended Patient Population. Data collection protocols should ensure that the relevant characteristics of the intended patient population (for example, in terms of age, gender, sex, race, and ethnicity), use, and measurement inputs are sufficiently represented in a sample of adequate size in the clinical study and training and test datasets, so that results can be reasonably generalized to the population of interest. This is important to manage any bias, promote appropriate and generalizable performance across the intended patient population, assess usability, and identify circumstances where the model may cipro gram positive underperform. Training Data Sets Are Independent of Test Sets.

Training and test datasets are selected and maintained to be appropriately independent of one another. All potential sources of dependence, including patient, data acquisition, and site factors, are considered and addressed to assure independence. Selected Reference Datasets Are Based Upon Best Available Methods cipro gram positive. Accepted, best available methods for developing a reference dataset (that is, a reference standard) ensure that clinically relevant and well characterized data are collected and the limitations of the reference are understood.

If available, accepted reference datasets in model development and testing that promote and demonstrate model robustness and generalizability across the intended patient population are used. Model Design Is Tailored to the Available cipro gram positive Data and Reflects the Intended Use of the Device. Model design is suited to the available data and supports the active mitigation of known risks, like overfitting, performance degradation, and security risks. The clinical benefits and risks related to the product are well understood, used to derive clinically meaningful performance goals for testing, and support that the product can safely and effectively achieve its intended use.

Considerations include the impact of both global and local performance and cipro gram positive uncertainty/variability in the device inputs, outputs, intended patient populations, and clinical use conditions. Focus Is Placed on the Performance of the Human-AI Team. Where the model has a "human in the loop," human factors considerations and the human interpretability of the model outputs are addressed with emphasis on the performance of the Human-AI team, rather than just the performance of the model in isolation. Testing Demonstrates Device Performance During Clinically cipro gram positive Relevant Conditions.

Statistically sound test plans are developed and executed to generate clinically relevant device performance information independently of the training data set. Considerations include the intended patient population, important subgroups, clinical environment and use by the Human-AI team, measurement inputs, and potential confounding factors. Users Are cipro gram positive Provided Clear, Essential Information. Users are provided ready access to clear, contextually relevant information that is appropriate for the intended audience (such as health care providers or patients) including.

The product's intended use and indications for use, performance of the model for appropriate subgroups, characteristics of the data used to train and test the model, acceptable inputs, known limitations, user interface interpretation, and clinical workflow integration of the model. Users are also made aware of device modifications and updates from real-world performance monitoring, the basis for decision-making cipro gram positive when available, and a means to communicate product concerns to the developer. Deployed Models Are Monitored for Performance and Re-training Risks Are Managed. Deployed models have the capability to be monitored in "real world" use with a focus on maintained or improved safety and performance.

Additionally, when cipro gram positive models are periodically or continually trained after deployment, there are appropriate controls in place to manage risks of overfitting, unintended bias, or degradation of the model (for example, dataset drift) that may impact the safety and performance of the model as it is used by the Human-AI team.Date and time. October 27, 2021, 11:00am - 5:00 pm EDTLocation. Via ZoomChair. Lorraine Greaves (Chair), Louise Pilote (Vice-chair)Secretariat.

The Digital buy canadian cipro Health Center of Excellence is spearheading this http://really-delicious.com/online-pharmacy-kamagra/ work for the FDA. Contact us directly at Digitalhealth@fda.hhs.gov, software@mhra.gov.uk, and mddpolicy-politiquesdim@hc-sc.gc.ca. Guiding principles Multi-Disciplinary Expertise Is Leveraged Throughout the Total Product Life Cycle. In-depth understanding buy canadian cipro of a model's intended integration into clinical workflow, and the desired benefits and associated patient risks, can help ensure that ML-enabled medical devices are safe and effective and address clinically meaningful needs over the lifecycle of the device.

Good Software Engineering and Security Practices Are Implemented. Model design is implemented with attention to the "fundamentals". Good software engineering practices, data quality assurance, buy canadian cipro data management, and robust cybersecurity practices. These practices include methodical risk management and design process that can appropriately capture and communicate design, implementation, and risk management decisions and rationale, as well as ensure data authenticity and integrity.

Clinical Study Participants and Data Sets Are Representative of the Intended Patient Population. Data collection protocols should ensure that the relevant characteristics of the intended patient population (for example, in terms of age, gender, sex, race, and ethnicity), use, and measurement inputs buy canadian cipro are sufficiently represented in a sample of adequate size in the clinical study and training and test datasets, so that results can be reasonably generalized to the population of interest. This is important to manage any bias, promote appropriate and generalizable performance across the intended patient population, assess usability, and identify circumstances where the model may underperform. Training Data Sets Are Independent of Test Sets.

Training and test datasets are selected and maintained to be appropriately independent of buy canadian cipro one another. All potential sources of dependence, including patient, data acquisition, and site factors, are considered and addressed to assure independence. Selected Reference Datasets Are Based Upon Best Available Methods. Accepted, best available methods for developing a reference dataset (that is, a reference standard) ensure that clinically relevant and well characterized data are buy canadian cipro collected and the limitations of the reference are understood.

If available, accepted reference datasets in model development and testing that promote and demonstrate model robustness and generalizability across the intended patient population are used. Model Design Is Tailored to the Available Data and Reflects the Intended Use of the Device. Model design is suited to the available data and supports buy canadian cipro the active mitigation of known risks, like overfitting, performance degradation, and security risks. The clinical benefits and risks related to the product are well understood, used to derive clinically meaningful performance goals for testing, and support that the product can safely and effectively achieve its intended use.

Considerations include the impact of both global and local performance and uncertainty/variability in the device inputs, outputs, intended patient populations, and clinical use conditions. Focus Is Placed on the Performance of the Human-AI Team. Where the model has a "human in the loop," human factors considerations and the human interpretability of the model outputs are addressed with emphasis on the performance of the Human-AI team, rather than just the performance of the model buy canadian cipro in isolation. Testing Demonstrates Device Performance During Clinically Relevant Conditions.

Statistically sound test plans are developed and executed to generate clinically relevant device performance information independently of the training data set. Considerations include the intended patient population, important subgroups, clinical environment and use by the Human-AI team, buy canadian cipro measurement inputs, and potential confounding factors. Users Are Provided Clear, Essential Information. Users are provided ready access to clear, contextually relevant information that is appropriate for the intended audience (such as health care providers or patients) including.

The product's intended use and indications for use, performance of the model for appropriate subgroups, characteristics of the data used to train and test the model, acceptable inputs, known limitations, user buy canadian cipro interface interpretation, and clinical workflow integration of the model. Users are also made aware of device modifications and updates from real-world performance monitoring, the basis for decision-making when available, and a means to communicate product concerns to the developer. Deployed Models Are Monitored for Performance and Re-training Risks Are Managed. Deployed models have buy canadian cipro the capability to be monitored in "real world" use with a focus on maintained or improved safety and performance.

Additionally, when models are periodically or continually trained after deployment, there are appropriate controls in place to manage risks of overfitting, unintended bias, or degradation of the model (for example, dataset drift) that may impact the safety and performance of the model as it is used by the Human-AI team.Date and time. October 27, 2021, 11:00am - 5:00 pm EDTLocation. Via ZoomChair buy canadian cipro. Lorraine Greaves (Chair), Louise Pilote (Vice-chair)Secretariat.

Jenna Griffiths, Laetitia Guillemette, Therapeutic Products Directorate (TPD)Participants. SAC-HPW members, Health Canada employees, guest presenter 11:00-11:05Welcome and opening remarksChief Medical Advisor, Health Canada and Senior Medical Advisor for Health Products and Food Branch 11:05-11:15Chair's address, review of agenda, introduction of members, review of buy canadian cipro affiliations and interests (A&I)Chair 11:15-11:25Session #1. Actions in response to past SAC-HPW recommendations to the Medical Devices DirectorateDirector General, Medical Devices Directorate 11:25-11:35Session #1. Committee discussions and feedbackSAC-HPW members 11:35-11:45Session #2.

Actions in response to past SAC-HPW recommendations to Drug buy canadian cipro DirectoratesManager, Office of Pediatrics and Patient Involvement 11:45-11:55Session #2. Committee discussions and feedbackSAC-HPW members 11:55-12:30Break 12:30-1:00Session #3. Update on medical devices foresight exerciseAssociate Director, Medical Devices Directorate 1:00-1:30Session #3. Committee questions and feedbackSAC-HPW members 1:30-2:00Session #4.

What should I watch for while taking Cipro?

Tell your doctor or health care professional if your symptoms do not improve.

Do not treat diarrhea with over the counter products. Contact your doctor if you have diarrhea that lasts more than 2 days or if it is severe and watery.

You may get drowsy or dizzy. Do not drive, use machinery, or do anything that needs mental alertness until you know how Cipro affects you. Do not stand or sit up quickly, especially if you are an older patient. This reduces the risk of dizzy or fainting spells.

Cipro can make you more sensitive to the sun. Keep out of the sun. If you cannot avoid being in the sun, wear protective clothing and use sunscreen. Do not use sun lamps or tanning beds/booths.

Avoid antacids, aluminum, calcium, iron, magnesium, and zinc products for 6 hours before and 2 hours after taking a dose of Cipro.

Can you take benadryl with cipro

EditorialAffiliations:1. Saw Swee Hock School of Public Health, National University of Singapore, Singapore 2. Infectious Diseases Translational Research Programme, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Institute for Health Innovation &. Technology, National University of Singapore, Singapore 3.

Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Infectious Diseases Translational Research Programme, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, SingaporePublication date:01 June 2021More about this publication?. The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as buy antibiotics, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details. The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health.

To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication.

Saw buy canadian cipro Swee Hock School generic cipro online of Public Health, National University of Singapore, Singapore 2. Infectious Diseases Translational Research Programme, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Institute for Health Innovation &. Technology, National University of Singapore, Singapore 3. Saw Swee Hock School buy canadian cipro of Public Health, National University of Singapore, Singapore, Infectious Diseases Translational Research Programme, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, SingaporePublication date:01 June 2021More about this publication?. The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as buy antibiotics, asthma, COPD, child lung health and the hazards of tobacco and air pollution.

Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details. The IJTLD is buy canadian cipro dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.Editorial BoardInformation for AuthorsSubscribe to this TitleInternational Journal of Tuberculosis and Lung DiseasePublic Health ActionIngenta Connect is not responsible for the content or availability of external websites.

Cipro hc otic ear drops

Junior clinicians are cipro hc otic ear drops fundamental other to clinical service provision. They are heavily involved in quality improvement and research and are becoming increasingly important in the delivery of medical education and clinical leadership.1 2 The volume of front-line clinical activity that junior clinicians undertake, and their cipro hc otic ear drops relative unfamiliarity with the status quo, place them in a unique position to contribute meaningfully to such activities.3 Currently, junior involvement in clinical leadership has been mostly supportive, often providing representational insight to larger and more senior leadership teams.4 However, the buy antibiotics cipro has presented a new opportunity for junior clinicians to contribute more substantively in leading healthcare systems, particularly in the form of junior clinical leadership teams.5Formal clinical leadership opportunities for junior clinicians do exist as fellowship roles. These experiences tend to focus on supporting leadership skills development under guidance from senior clinical leaders and cipro hc otic ear drops are often combined with a designated project or a formalised educational curriculum.6 In these roles, junior clinicians are effectively able to contribute to successful legacy projects, culture change and improved healthcare outcomes.7 …As doctors, we find it disquieting to read the paper ‘Depression, quality of life and coping style among Thai doctors before their first year of residency training’.1 It reminds us to turn our attention to Chinese resident training system, a standardised training programme that will be generalised in all provinces of China this year.Supplemental material[postgradmedj-2020-138556supp001.pdf]It has been generally believed that well-trained doctors are essential for the safe patient care and high-quality healthcare system.

However, Chinese medical graduates are cipro hc otic ear drops not fully trained doctors when they leave school due to lack of enough clinical practice and training. Therefore, resident training is a key stage for medical graduates to acquire skills and knowledge before cipro hc otic ear drops becoming professionals.2 As is known to all, Chinese government has made great efforts to meet the growing demand for medical services and improve the work performance of senior doctors and residents in the past decades.2 Among these attempts, the standardised training system for residents (STSR) started in 2014 is particularly important. The STSR, jointly issued by the National Health Commission of the cipro hc otic ear drops People’s Republic of China with six other departments, is a national project that provides systematic and standardised training for residents, and is also one of the important steps in the reform of Chinese medical system.3 The STSR is mandatory and will take up to 3 years depending on the educational level of participants.

In detail, the training period of Medical Bachelor (MB), Master ….

Junior clinicians buy canadian cipro are fundamental look at this web-site to clinical service provision. They are heavily involved in quality improvement and research and are becoming increasingly important in the delivery of medical education and clinical leadership.1 2 The volume of front-line clinical activity that junior clinicians undertake, and their relative unfamiliarity with the status quo, place them in a unique position to contribute meaningfully to such activities.3 Currently, junior involvement in clinical leadership has been mostly supportive, often providing representational insight to larger and more senior buy canadian cipro leadership teams.4 However, the buy antibiotics cipro has presented a new opportunity for junior clinicians to contribute more substantively in leading healthcare systems, particularly in the form of junior clinical leadership teams.5Formal clinical leadership opportunities for junior clinicians do exist as fellowship roles. These experiences tend to focus on supporting leadership skills development under guidance from senior clinical leaders and are often combined with a designated project or a formalised educational curriculum.6 In these roles, junior clinicians are effectively able to contribute to successful legacy projects, culture change and improved healthcare outcomes.7 …As doctors, we find it disquieting to read the paper ‘Depression, quality of life and coping style among Thai doctors before their first buy canadian cipro year of residency training’.1 It reminds us to turn our attention to Chinese resident training system, a standardised training programme that will be generalised in all provinces of China this year.Supplemental material[postgradmedj-2020-138556supp001.pdf]It has been generally believed that well-trained doctors are essential for the safe patient care and high-quality healthcare system. However, Chinese medical graduates are not fully trained doctors when they leave school due to lack of enough clinical practice buy canadian cipro and training.

Therefore, resident training is buy canadian cipro a key stage for medical graduates to acquire skills and knowledge before becoming professionals.2 As is known to all, Chinese government has made great efforts to meet the growing demand for medical services and improve the work performance of senior doctors and residents in the past decades.2 Among these attempts, the standardised training system for residents (STSR) started in 2014 is particularly important. The STSR, jointly issued by the National Health Commission of the People’s Republic of China with six other departments, is a national project that provides systematic buy canadian cipro and standardised training for residents, and is also one of the important steps in the reform of Chinese medical system.3 The STSR is mandatory and will take up to 3 years depending on the educational level of participants. In detail, the training period of Medical Bachelor (MB), Master ….

Cipro causes diarrhea

Start Preamble Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services cipro causes diarrhea (HHS). Notice. Correction. The Office of the Secretary has extended the application period for accepting application submissions from qualified individuals who wish to be considered for membership on the National Advisory Committee on Seniors and Disasters (NACSD).

Up to seven new voting members with expertise in senior medical disaster planning, preparedness, response, or recovery will be selected for the Committee. Please visit the NACSD website at www.phe.gov/​nacsd for all application submission information and instructions. Application submissions will be accepted until July 12, 2021. Application Period.

The application period has been extended and will now end on July 12, 2021. Start Further Info Maxine Kellman, DVM, Ph.D., PMP, Designated Federal Official for National Advisory Committees, Washington, DC, Office (202) 260-0447 or email maxine.kellman@hhs.gov. Corrections. 1.

Correction to final notice published in the Federal Register on May 13, 2021 entitled “National Advisory Committee on Seniors and Disasters.” Amendment to the application period which has been extended and applications will be accepted until July 12, 2021. Start Signature Karuna Seshasai, Executive Secretary to the Department, U.S. Department of Health and Human Services. End Signature End Further Info End Preamble [FR Doc.

2021-14053 Filed 6-30-21. 8:45 am]BILLING CODE 4150-37-PStart Preamble Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS). Notice. Correction.

The Office of the Secretary has extended the application period for accepting application submissions from qualified individuals who wish to be considered for membership on the National Advisory Committee on Individuals with Disabilities and Disasters (NACIDD). Up to seven new voting members with expertise disability accessibility, medical disaster planning, preparedness, response, or recovery will be selected for the Committee. Please visit the NACIDD website at www.phe.gov/​nacidd for all application submission information and Start Printed Page 35097instructions. Application submissions will be accepted until July 12, 2021.

The application period has been extended and will now end on July 12, 2021. Start Further Info Maxine Kellman, DVM, Ph.D., PMP, Designated Federal Official for National Advisory Committees, Washington, DC, Office (202) 260-0447 or email maxine.kellman@hhs.gov. Corrections 1. Correction to final notice published in the Federal Register on May 13, 2021 entitled “National Advisory Committee on Individuals with Disabilities and Disasters.” Amendment to the application period which has been extended and applications will be accepted until July 12, 2021.

Start Signature Karuna Seshasai, Executive Secretary to the Department, U.S. Department of Health and Human Services. End Signature End Further Info End Preamble [FR Doc. 2021-14059 Filed 6-30-21.

Start Preamble Office of How to get zithromax without prescription the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services buy canadian cipro (HHS). Notice. Correction. The Office of the Secretary has extended the application period for accepting application submissions from qualified individuals who wish to be considered for membership on the National Advisory Committee on Seniors and Disasters (NACSD). Up to seven new voting members with expertise in senior medical disaster planning, preparedness, response, or recovery will be selected for the Committee.

Please visit the NACSD website at www.phe.gov/​nacsd for all application submission information and instructions. Application submissions will be accepted until July 12, 2021. Application Period. The application period has been extended and will now end on July 12, 2021. Start Further Info Maxine Kellman, DVM, Ph.D., PMP, Designated Federal Official for National Advisory Committees, Washington, DC, Office (202) 260-0447 or email maxine.kellman@hhs.gov.

Corrections. 1. Correction to final notice published in the Federal Register on May 13, 2021 entitled “National Advisory Committee on Seniors and Disasters.” Amendment to the application period which has been extended and applications will be accepted until July 12, 2021. Start Signature Karuna Seshasai, Executive Secretary to the Department, U.S. Department of Health and Human Services.

End Signature End Further Info End Preamble [FR Doc. 2021-14053 Filed 6-30-21. 8:45 am]BILLING CODE 4150-37-PStart Preamble Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS). Notice. Correction.

The Office of the Secretary has extended the application period for accepting application submissions from qualified individuals who wish to be considered for membership on the National Advisory Committee on Individuals with Disabilities and Disasters (NACIDD). Up to seven new voting members with expertise disability accessibility, medical disaster planning, preparedness, response, or recovery will be selected for the Committee. Please visit the NACIDD website at www.phe.gov/​nacidd for all application submission information and Start Printed Page 35097instructions. Application submissions will be accepted until July 12, 2021. The application period has been extended and will now end on July 12, 2021.

Start Further Info Maxine Kellman, DVM, Ph.D., PMP, Designated Federal Official for National Advisory Committees, Washington, DC, Office (202) 260-0447 or email maxine.kellman@hhs.gov. Corrections 1. Correction to final notice published in the Federal Register on May 13, 2021 entitled “National Advisory Committee on Individuals with Disabilities and Disasters.” Amendment to the application period which has been extended and applications will be accepted until July 12, 2021. Start Signature Karuna Seshasai, Executive Secretary to the Department, U.S. Department of Health and Human Services.

End Signature End Further Info End Preamble [FR Doc. 2021-14059 Filed 6-30-21. 8:45 am]BILLING CODE 4150-37-P.